WO2012087976A3 - Novel inhibitors of hepatitis c virus replication - Google Patents
Novel inhibitors of hepatitis c virus replication Download PDFInfo
- Publication number
- WO2012087976A3 WO2012087976A3 PCT/US2011/065925 US2011065925W WO2012087976A3 WO 2012087976 A3 WO2012087976 A3 WO 2012087976A3 US 2011065925 W US2011065925 W US 2011065925W WO 2012087976 A3 WO2012087976 A3 WO 2012087976A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hepatitis
- methods
- virus replication
- novel inhibitors
- subject compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
The embodiments provide compounds of the general Formulae XV, XVI, XVII and XVIII as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201061425718P | 2010-12-21 | 2010-12-21 | |
US61/425,718 | 2010-12-21 | ||
US201161454438P | 2011-03-18 | 2011-03-18 | |
US61/454,438 | 2011-03-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012087976A2 WO2012087976A2 (en) | 2012-06-28 |
WO2012087976A3 true WO2012087976A3 (en) | 2012-11-29 |
Family
ID=46314813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/065925 WO2012087976A2 (en) | 2010-12-21 | 2011-12-19 | Novel inhibitors of hepatitis c virus replication |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012087976A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9393256B2 (en) | 2011-09-16 | 2016-07-19 | Gilead Pharmasset Llc | Methods for treating HCV |
CN107235965A (en) * | 2016-03-29 | 2017-10-10 | 上海医药工业研究院 | A kind of preparation method of his Wei of Dacca |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP3622A (en) | 2009-05-13 | 2016-03-02 | Gilead Sciences Inc | Antiviral compounds |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
DK2455376T3 (en) | 2009-06-11 | 2015-03-02 | Abbvie Bahamas Ltd | Heterocyclic compounds as inhibitors of hepatitis C virus (HCV) |
AR079528A1 (en) | 2009-12-18 | 2012-02-01 | Idenix Pharmaceuticals Inc | 5,5-FUSIONED ARYLENE OR HETEROARYLENE INHIBITORS OF HEPATITIS C VIRUS |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
TWI640526B (en) | 2010-11-17 | 2018-11-11 | 基利法瑪席特有限責任公司 | Antiviral compounds |
US8552047B2 (en) | 2011-02-07 | 2013-10-08 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9546160B2 (en) | 2011-05-12 | 2017-01-17 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
ME02196B (en) | 2011-11-16 | 2016-02-20 | Gilead Pharmasset Llc | Condensed imidazolylimidazoles as antiviral compounds |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
US9326973B2 (en) | 2012-01-13 | 2016-05-03 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US20130309196A1 (en) | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
PL2950786T3 (en) | 2013-01-31 | 2020-05-18 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
US20150023913A1 (en) | 2013-07-02 | 2015-01-22 | Bristol-Myers Squibb Company | Hepatitis C Virus Inhibitors |
US9717712B2 (en) | 2013-07-02 | 2017-08-01 | Bristol-Myers Squibb Company | Combinations comprising tricyclohexadecahexaene derivatives for use in the treatment of hepatitis C virus |
EP3021845A1 (en) | 2013-07-17 | 2016-05-25 | Bristol-Myers Squibb Company | Combinations comprising biphenyl derivatives for use in the treatment of hcv |
PL3038601T3 (en) | 2013-08-27 | 2020-08-24 | Gilead Pharmasset Llc | Combination formulation of two antiviral compounds |
EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
TWI721947B (en) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | Solid forms of an antiviral compound |
CN105753944B (en) * | 2014-12-19 | 2019-10-01 | 正大天晴药业集团股份有限公司 | His Wei of Dacca and its derivative prepare intermediate |
CN106032388A (en) * | 2015-03-11 | 2016-10-19 | 浙江九洲药业股份有限公司 | Preparation method of Daclatasvir compound |
US10617675B2 (en) | 2015-08-06 | 2020-04-14 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
CN105461701A (en) * | 2015-12-14 | 2016-04-06 | 上海步越化工科技有限公司 | Novel method for synthesizing anti-hepatitis C virus novel medicine daclatasvir |
CN105753844A (en) * | 2016-02-16 | 2016-07-13 | 江苏苏利精细化工股份有限公司 | Novel method for synthesizing dimethyl dicarbamate dihydrochloride compound |
CN105777719A (en) * | 2016-03-29 | 2016-07-20 | 安徽联创生物医药股份有限公司 | Synthesis method of Daclatasvir |
CN107235884B (en) * | 2016-03-29 | 2021-03-26 | 上海医药工业研究院 | Daclatasvir intermediate and preparation method thereof |
CN106256825A (en) * | 2016-07-04 | 2016-12-28 | 四川同晟生物医药有限公司 | The synthetic method of his Wei of Dacca |
KR20240038149A (en) | 2017-04-26 | 2024-03-22 | 바실리어 파마슈티카 인터내셔널 리미티드 | Processes for the preparation of furazanobenzimidazoles and crystalline forms thereof |
CN108640847A (en) * | 2018-06-25 | 2018-10-12 | 青岛大学 | Adjacent aminobenzophenone class compound of the one kind containing fluorene group |
KR20220004996A (en) | 2019-04-03 | 2022-01-12 | 알리고스 테라퓨틱스 인코포레이티드 | pyrrole compound |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008021927A2 (en) * | 2006-08-11 | 2008-02-21 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2009102318A1 (en) * | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2010065668A1 (en) * | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
WO2010091413A1 (en) * | 2009-02-09 | 2010-08-12 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
WO2010096462A1 (en) * | 2009-02-17 | 2010-08-26 | Enanta Pharmaceuticals, Inc | Linked diimidazole derivatives |
WO2010099527A1 (en) * | 2009-02-27 | 2010-09-02 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2010111483A1 (en) * | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
WO2010132601A1 (en) * | 2009-05-13 | 2010-11-18 | Gilead Sciences, Inc. | Antiviral compounds |
US20100316607A1 (en) * | 2009-06-16 | 2010-12-16 | Yat Sun Or | Hepatitis c virus inhibitors |
WO2011009084A2 (en) * | 2009-07-16 | 2011-01-20 | Vertex Pharmaceuticals Incorporated | Benzimidazole analogues for the treatment or prevention of flavivirus infections |
WO2011031934A1 (en) * | 2009-09-11 | 2011-03-17 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2011060000A1 (en) * | 2009-11-12 | 2011-05-19 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2011150243A1 (en) * | 2010-05-28 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
WO2011149856A1 (en) * | 2010-05-24 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
-
2011
- 2011-12-19 WO PCT/US2011/065925 patent/WO2012087976A2/en active Application Filing
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008021927A2 (en) * | 2006-08-11 | 2008-02-21 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2009102318A1 (en) * | 2008-02-12 | 2009-08-20 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2010065668A1 (en) * | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
WO2010065681A1 (en) * | 2008-12-03 | 2010-06-10 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
WO2010091413A1 (en) * | 2009-02-09 | 2010-08-12 | Enanta Pharmaceuticals, Inc. | Linked dibenzimidazole derivatives |
WO2010096462A1 (en) * | 2009-02-17 | 2010-08-26 | Enanta Pharmaceuticals, Inc | Linked diimidazole derivatives |
WO2010099527A1 (en) * | 2009-02-27 | 2010-09-02 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2010111483A1 (en) * | 2009-03-27 | 2010-09-30 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus replication |
WO2010132601A1 (en) * | 2009-05-13 | 2010-11-18 | Gilead Sciences, Inc. | Antiviral compounds |
US20100316607A1 (en) * | 2009-06-16 | 2010-12-16 | Yat Sun Or | Hepatitis c virus inhibitors |
WO2011009084A2 (en) * | 2009-07-16 | 2011-01-20 | Vertex Pharmaceuticals Incorporated | Benzimidazole analogues for the treatment or prevention of flavivirus infections |
WO2011031934A1 (en) * | 2009-09-11 | 2011-03-17 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
WO2011060000A1 (en) * | 2009-11-12 | 2011-05-19 | Bristol-Myers Squibb Company | Hepatitis c virus inhibitors |
WO2011149856A1 (en) * | 2010-05-24 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
WO2011150243A1 (en) * | 2010-05-28 | 2011-12-01 | Presidio Pharmaceuticals, Inc. | Inhibitors of hcv ns5a |
Non-Patent Citations (260)
Title |
---|
DATABASE STN accession no. 007833- 81-9 * |
DATABASE STN accession no. 007881- 01-7 * |
DATABASE STN accession no. 007881-01-7 * |
DATABASE STN accession no. 007882-25-8 * |
DATABASE STN accession no. 007882-26-9 * |
DATABASE STN accession no. 007882-29-2 * |
DATABASE STN accession no. 007882-36-1 * |
DATABASE STN accession no. 007882-3-7-2 * |
DATABASE STN accession no. 007882-37-2 * |
DATABASE STN accession no. 007882-65-6 * |
DATABASE STN accession no. 007882-67- 8 * |
DATABASE STN accession no. 007882-67-8 * |
DATABASE STN accession no. 007882-68-9 * |
DATABASE STN accession no. 007882-69-0 * |
DATABASE STN accession no. 007883-58-0 * |
DATABASE STN accession no. 007883-59-1 * |
DATABASE STN accession no. 007883-60-4 * |
DATABASE STN accession no. 007883-61-5 * |
DATABASE STN accession no. 007883-62-6 * |
DATABASE STN accession no. 007883-63-7 * |
DATABASE STN accession no. 007883-80-3 * |
DATABASE STN accession no. 007883-80-8 * |
DATABASE STN accession no. 007883-81-9 * |
DATABASE STN accession no. 007883-87-5 * |
DATABASE STN accession no. 007883-92- 2 * |
DATABASE STN accession no. 007883-92-2 * |
DATABASE STN accession no. 007883-93-3 * |
DATABASE STN accession no. 007883-94-4 * |
DATABASE STN accession no. 007883-95-5 * |
DATABASE STN accession no. 007883-96-6 * |
DATABASE STN accession no. 007883-97-7 * |
DATABASE STN accession no. 007883-98-8 * |
DATABASE STN accession no. 007883-99-9 * |
DATABASE STN accession no. 007884-00-5 * |
DATABASE STN accession no. 007884-01-6 * |
DATABASE STN accession no. 007884-01-9 * |
DATABASE STN accession no. 007884-02-7 * |
DATABASE STN accession no. 007884-03-8 * |
DATABASE STN accession no. 007884-06-1 * |
DATABASE STN accession no. 007884-07-2 * |
DATABASE STN accession no. 007884-07L2 * |
DATABASE STN accession no. 007884-09-4 * |
DATABASE STN accession no. 007884-13-0 * |
DATABASE STN accession no. 007884-14-1 * |
DATABASE STN accession no. 007884-85-6 * |
DATABASE STN accession no. 007884-89-0 * |
DATABASE STN accession no. 009119-84-9 * |
DATABASE STN accession no. 087346-53-9 * |
DATABASE STN accession no. 087346-55-1 * |
DATABASE STN accession no. 087346-56-2 * |
DATABASE STN accession no. 087346-57-3 * |
DATABASE STN accession no. 087346-58-4 * |
DATABASE STN accession no. 087346-59-5 * |
DATABASE STN accession no. 087346-60-8 * |
DATABASE STN accession no. 087346-61-9 * |
DATABASE STN accession no. 087346-62-0 * |
DATABASE STN accession no. 087346-65-3 * |
DATABASE STN accession no. 087346-70-0 * |
DATABASE STN accession no. 087346-72-2 * |
DATABASE STN accession no. 087346-73-3 * |
DATABASE STN accession no. 087346-75-5 * |
DATABASE STN accession no. 087346-76-6 * |
DATABASE STN accession no. 087346-81-3 * |
DATABASE STN accession no. 087346-84-6 * |
DATABASE STN accession no. 087346-91-5 * |
DATABASE STN accession no. 22866-17-3 * |
DATABASE STN accession no. 228668-67-4 * |
DATABASE STN accession no. 228668-68-5 * |
DATABASE STN accession no. 228668-73-2 * |
DATABASE STN accession no. 228668-74-3 * |
DATABASE STN accession no. 228668-75-4 * |
DATABASE STN accession no. 228668-76-5 * |
DATABASE STN accession no. 228668-77-6 * |
DATABASE STN accession no. 228668-78-7 * |
DATABASE STN accession no. 228668-79-8 * |
DATABASE STN accession no. 228668-80-1 * |
DATABASE STN accession no. 228668-81-2 * |
DATABASE STN accession no. 228668-82-3 * |
DATABASE STN accession no. 228670-54-9 * |
DATABASE STN accession no. 228670-61-8 * |
DATABASE STN accession no. 228670-62-9 * |
DATABASE STN accession no. 228670-63-0 * |
DATABASE STN accession no. 228670-64-1 * |
DATABASE STN accession no. 228670-65-2 * |
DATABASE STN accession no. 228671-24-6 * |
DATABASE STN accession no. 228671-70-2 * |
DATABASE STN accession no. 228671-74-6 * |
DATABASE STN accession no. 228671-79-1 * |
DATABASE STN accession no. 228671-81-5 * |
DATABASE STN accession no. 228671-92-8 * |
DATABASE STN accession no. 228671-93-9 * |
DATABASE STN accession no. 228671-99-5 * |
DATABASE STN accession no. 228672-00-1 * |
DATABASE STN accession no. 228965-93-2 * |
DATABASE STN accession no. 228965-95-4 * |
DATABASE STN accession no. 228966-02-6 * |
DATABASE STN accession no. 228966-03-7 * |
DATABASE STN accession no. 228966-04-8 * |
DATABASE STN accession no. 228966-06-0 * |
DATABASE STN accession no. 228966-07-1 * |
DATABASE STN accession no. 228966-08-2 * |
DATABASE STN accession no. 228966-09-3 * |
DATABASE STN accession no. 228966-10-6 * |
DATABASE STN accession no. 228966-17 3 * |
DATABASE STN accession no. 228966-18-4 * |
DATABASE STN accession no. 228966-19-5 * |
DATABASE STN accession no. 228966-71-9 * |
DATABASE STN accession no. 228966-73-1 * |
DATABASE STN accession no. 228966-88-8 * |
DATABASE STN accession no. 228966-89-9 * |
DATABASE STN accession no. 228966-90-2 * |
DATABASE STN accession no. 228967-06-3 * |
DATABASE STN accession no. 228967-07-4 * |
DATABASE STN accession no. 228967-08-5 * |
DATABASE STN accession no. 228968-76-0 * |
DATABASE STN accession no. 228968-76-0. * |
DATABASE STN accession no. 239551-98-9 * |
DATABASE STN accession no. 23959-40-5 * |
DATABASE STN accession no. 239651-88-7 * |
DATABASE STN accession no. 239651-89-8 * |
DATABASE STN accession no. 239651-90-1 * |
DATABASE STN accession no. 239651-91-2 * |
DATABASE STN accession no. 239651-92-3 * |
DATABASE STN accession no. 239651-93-4 * |
DATABASE STN accession no. 239651-96-7 * |
DATABASE STN accession no. 239651-97-8 * |
DATABASE STN accession no. 239651-99-0 * |
DATABASE STN accession no. 239652-00-6 * |
DATABASE STN accession no. 239652-02-8 * |
DATABASE STN accession no. 239652-03-9 * |
DATABASE STN accession no. 239652-04-0 * |
DATABASE STN accession no. 239652-05-1 * |
DATABASE STN accession no. 239652-06-2 * |
DATABASE STN accession no. 239652-07-3 * |
DATABASE STN accession no. 239652-08-4 * |
DATABASE STN accession no. 239652-O1-7 * |
DATABASE STN accession no. 239659-22-3 * |
DATABASE STN accession no. 239659-23-4 * |
DATABASE STN accession no. 239659-25-6 * |
DATABASE STN accession no. 239659-27-8 * |
DATABASE STN accession no. 239659-29-0 * |
DATABASE STN accession no. 239659-32-5 * |
DATABASE STN accession no. 239659-33-6 * |
DATABASE STN accession no. 239659-35-8 * |
DATABASE STN accession no. 239659-36-9 * |
DATABASE STN accession no. 239659-37-0 * |
DATABASE STN accession no. 239659-38-1 * |
DATABASE STN accession no. 239659-39-2 * |
DATABASE STN accession no. 239659-3a-3 * |
DATABASE STN accession no. 239659-41-6 * |
DATABASE STN accession no. 239659-44-9 * |
DATABASE STN accession no. 240883- 60-6 * |
DATABASE STN accession no. 240883-53-7 * |
DATABASE STN accession no. 240883-55-9 * |
DATABASE STN accession no. 240883-56-0 * |
DATABASE STN accession no. 240883-5711 * |
DATABASE STN accession no. 240883-61-7 * |
DATABASE STN accession no. 240883-63-9 * |
DATABASE STN accession no. 240883-65-1 * |
DATABASE STN accession no. 240883-66-2 * |
DATABASE STN accession no. 240883-67-3 * |
DATABASE STN accession no. 240883-69- 5 * |
DATABASE STN accession no. 240883-71-9 * |
DATABASE STN accession no. 240883-73-1 * |
DATABASE STN accession no. 240883-75-3 * |
DATABASE STN accession no. 240883-76-4 * |
DATABASE STN accession no. 240883-77-5 * |
DATABASE STN accession no. 240883-79-7 * |
DATABASE STN accession no. 240883-81-1 * |
DATABASE STN accession no. 240883-83-3 * |
DATABASE STN accession no. 240883-85-5 * |
DATABASE STN accession no. 240890-46-3 * |
DATABASE STN accession no. 240890-48-5 * |
DATABASE STN accession no. 240890-50-9 * |
DATABASE STN accession no. 240890-51-0 * |
DATABASE STN accession no. 240890-53-2 * |
DATABASE STN accession no. 240890-54-3 * |
DATABASE STN accession no. 240890-56-5 * |
DATABASE STN accession no. 240890-58-7 * |
DATABASE STN accession no. 240890-60-1 * |
DATABASE STN accession no. 240890-61-2 * |
DATABASE STN accession no. 240890-64-5 * |
DATABASE STN accession no. 240890-65-6 * |
DATABASE STN accession no. 240890-67-8 * |
DATABASE STN accession no. 240890-68-9 * |
DATABASE STN accession no. 240890-71-4 * |
DATABASE STN accession no. 240890-72-5 * |
DATABASE STN accession no. 240890-74-7 * |
DATABASE STN accession no. 240890-75-8 * |
DATABASE STN accession no. 240890-77-0 * |
DATABASE STN accession no. 240890-78-1 * |
DATABASE STN accession no. 242085- 55-7 * |
DATABASE STN accession no. 242085-51-3 * |
DATABASE STN accession no. 242085-52-4 * |
DATABASE STN accession no. 242085-53-5 * |
DATABASE STN accession no. 242085-54-6 * |
DATABASE STN accession no. 242085-56-8 * |
DATABASE STN accession no. 242085-58-0 * |
DATABASE STN accession no. 242085-59-1 * |
DATABASE STN accession no. 242085-60-4 * |
DATABASE STN accession no. 242085-62-6 * |
DATABASE STN accession no. 242085-63- 7 * |
DATABASE STN accession no. 242085-64-8 * |
DATABASE STN accession no. 242085-65-9 * |
DATABASE STN accession no. 242085-66-0 * |
DATABASE STN accession no. 242085-67-1 * |
DATABASE STN accession no. 242085-68-2 * |
DATABASE STN accession no. 242085-69-3 * |
DATABASE STN accession no. 242085-70-6 * |
DATABASE STN accession no. 242088-24-9 * |
DATABASE STN accession no. 242088-25-0 * |
DATABASE STN accession no. 246469- 50-0 * |
DATABASE STN accession no. 246469-42-0 * |
DATABASE STN accession no. 246469-43-1 * |
DATABASE STN accession no. 246469-47-5 * |
DATABASE STN accession no. 246469-49.17 * |
DATABASE STN accession no. 246469-51-1 * |
DATABASE STN accession no. 246469-52-2 * |
DATABASE STN accession no. 246469-56-6 * |
DATABASE STN accession no. 246469-57-7 * |
DATABASE STN accession no. 246469-59-9 * |
DATABASE STN accession no. 246469-60- 2 * |
DATABASE STN accession no. 246469-62-4 * |
DATABASE STN accession no. 246471-28-2 * |
DATABASE STN accession no. 246471-31-7 * |
DATABASE STN accession no. 246471-32-8 * |
DATABASE STN accession no. 246471-40-8 * |
DATABASE STN accession no. 246471-41-9 * |
DATABASE STN accession no. 246471-42-0 * |
DATABASE STN accession no. 256388-45-0 * |
DATABASE STN accession no. 258309-88-4 * |
DATABASE STN accession no. 258309-89-5 * |
DATABASE STN accession no. 258309-90-8 * |
DATABASE STN accession no. 258309-91-9 * |
DATABASE STN accession no. 258309-92-0 * |
DATABASE STN accession no. 258309-93-1 * |
DATABASE STN accession no. 258309-94-2 * |
DATABASE STN accession no. 258309-96-4 * |
DATABASE STN accession no. 258309-97-5 * |
DATABASE STN accession no. 259309-95-3 * |
DATABASE STN accession no. 262317-58-7 * |
DATABASE STN accession no. 275032-59-1 * |
DATABASE STN accession no. 275032-61-5 * |
DATABASE STN accession no. 275032-62-6 * |
DATABASE STN accession no. 275032-63-7 * |
DATABASE STN accession no. 275032-85- 3 * |
DATABASE STN accession no. 275032-86-4 * |
DATABASE STN accession no. 275032-87-5 * |
DATABASE STN accession no. 275032-88-6 * |
DATABASE STN accession no. 275033- 55-0 * |
DATABASE STN accession no. 275033-67-4 * |
DATABASE STN accession no. 275033-69-6 * |
DATABASE STN accession no. 307303- 61-2 * |
DATABASE STN accession no. 307303-62-3 * |
DATABASE STN accession no. 350925-63-3 * |
DATABASE STN accession no. 350925-64-2 * |
DATABASE STN accession no. 351332-49-4 * |
DATABASE STN accession no. 351332-50-7 * |
DATABASE STN accession no. 351332-72-3 * |
DATABASE STN REGISTRY NUMBERS accession no. 228671-12-2 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9393256B2 (en) | 2011-09-16 | 2016-07-19 | Gilead Pharmasset Llc | Methods for treating HCV |
CN107235965A (en) * | 2016-03-29 | 2017-10-10 | 上海医药工业研究院 | A kind of preparation method of his Wei of Dacca |
Also Published As
Publication number | Publication date |
---|---|
WO2012087976A2 (en) | 2012-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012087976A3 (en) | Novel inhibitors of hepatitis c virus replication | |
WO2008137779A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
WO2009142842A3 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
MX2012003171A (en) | Novel macrocyclic inhibitors of hepatitis c virus replication. | |
WO2008005511A8 (en) | Novel inhibitors of hepatitis c virus replication | |
TN2009000481A1 (en) | Novel peptide inhibitors of hepatitis c virus replication | |
WO2007047146A3 (en) | Inhibitors of viral replication | |
WO2009134616A8 (en) | Novel inhibitors of hepatitis c virus replication | |
IN2012DN02693A (en) | ||
WO2008100867A3 (en) | Novel inhibitors hepatitis c virus replication | |
TW200740851A (en) | Novel macrocyclic inhibitors of hepatitis C virus replication | |
WO2005095403A3 (en) | Macrocyclic compounds as inhibitors of viral replication | |
WO2012083122A8 (en) | Inhibitors of influenza viruses replication | |
TNSN06308A1 (en) | Macrocyclic compounds as inhibitors of viral replication | |
WO2013059278A3 (en) | Hepatitis c virus inhibitors | |
EP2551266A4 (en) | 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof | |
TN2010000468A1 (en) | Novel macrocyclic inhibitors of hepatitis c virus replication | |
UA95455C2 (en) | Macrocyclic inhibitors of hepatitis c virus replication | |
CU20090182A7 (en) | NEW MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | |
CU20090188A7 (en) | NEW INHIBITING PEPTIDES OF HEPATITIS C VIRUS REPLICATION | |
TW200611905A (en) | Macrocyclic compounds as inhibitors of viral replication | |
UA84579C2 (en) | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hepatitis c virus replication | |
WO2012106722A3 (en) | Treatment of bacterial infections |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11850070 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11850070 Country of ref document: EP Kind code of ref document: A2 |